Novo Nordisk announced that the FDA has approved a 2.0 mg dose of Ozempic® a glucagon-like peptide-1 analogue for the treatment of adults with type 2 diabetes.
[Full Journal Title]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
173422
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
